PATENT CLAIM ANALYSIS

Application Number: 16311593
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["514", "017700"]

Abstract:
This invention relates to inhibitory peptides which bind to α-synuclein molecules and inhibit α-synuclein amyloidogenic aggregation, α-synuclein cytotoxicity, and spread of α-synuclein. Methods of making and using the inhibitory peptides (e.g. to treat subjects having conditions or diseases that are mediated by α-synuclein, such as Parkinson's disease, dementia with Lewy bodies, or MSA) are described.

Claim (Index 17):
The method of  claim 16 , wherein the presence of complexes formed between \u03b1-synuclein amyloid fibrils and the peptide is monitored using a detectable label that is coupled to the peptide.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 98.0
- Lexical Diversity: 1.40426
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13255244', '13899674', '14138347', '12702175', '15313810']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7664265169950818
- 35 USC 102 Novelty (BERT): 0.5537247703405385
- Combined Prediction Score: 0.7451563423296275
- Mean Citation Score: 357.06637800000016
- Max Citation Score: 402.39343
- Similarity Product: 323.93661963385114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test